Scientific Articles on Psychedelics: Difference between revisions
From DMT-Nexus Wiki
Jump to navigationJump to search
TheTraveler (talk | contribs) |
Endlessness (talk | contribs) |
||
| (7 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{ShowInfo|[[Image:Error.png]]|'''Note:'''|This page is a work in progress -- its content throughout is not yet complete.}} | {{ShowInfo|[[Image:Error.png]]|'''Note:'''|This page is a work in progress -- its content throughout is not yet complete.}}<br /> | ||
==Ayahuasca== | ==Ayahuasca== | ||
{{FileReference | {{FileReference | ||
| Line 104: | Line 102: | ||
| | | | ||
}} | }} | ||
==DMT== | ==DMT== | ||
| Line 127: | Line 126: | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media:DMT psychopharmacology.pdf|DMT psychopharmacology]] | |[[Media:DMT psychopharmacology.pdf|DMT psychopharmacology]] | ||
| | | | ||
}} | }} | ||
==Ibogaine== | ==Ibogaine== | ||
| Line 166: | Line 160: | ||
| | | | ||
}} | }} | ||
==LSD== | ==LSD== | ||
| Line 179: | Line 174: | ||
| | | | ||
}} | }} | ||
==Peyote== | ==Peyote== | ||
| Line 198: | Line 194: | ||
| | | | ||
}} | }} | ||
==Psilocybin== | ==Psilocybin== | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:cluster headache lsd psilocybin.pdf|Cluster headache lsd psilocybin]] | ||
| | | | ||
|0px | |0px | ||
| Line 208: | Line 205: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:effects of psilocybin on humans.pdf|Effects of psilocybin on humans]] | ||
| | | | ||
|0px | |0px | ||
| Line 214: | Line 211: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:effects of psilocybin on perception of time.pdf|Effects of psilocybin on perception of time]] | ||
| | | | ||
|0px | |0px | ||
| Line 220: | Line 217: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:psilocybin and mystical experiences.pdf|Psilocybin and mystical experiences]] | ||
| | | | ||
|0px | |0px | ||
| Line 226: | Line 223: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:Psilocybin and OCD.pdf|Psilocybin and OCD]] | ||
| | | | ||
|0px | |0px | ||
| Line 232: | Line 229: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:psilocybin investigator brochure.pdf|Psilocybin investigator brochure]] | ||
| | | | ||
|0px | |0px | ||
| Line 238: | Line 235: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:psilocybin, attention and working memory.pdf|Psilocybin, attention and working memory]] | ||
| | | | ||
|0px | |0px | ||
| Line 244: | Line 241: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:psychedelic mushrooms in buddhist tradition.pdf|Psychedelic mushrooms in buddhist tradition]] | ||
| | | | ||
}} | }} | ||
==Salvia Divinorum== | ==Salvia Divinorum== | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:salvia divinorum pattern of use.pdf|Salvia divinorum pattern of use]] | ||
| | | | ||
|0px | |0px | ||
| Line 266: | Line 255: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:Salv_A_PNAS.pdf|Salv_A_PNAS]] | ||
| | | | ||
}} | }} | ||
==Other== | ==Other== | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:Jf00077a037.pdf|Alkaloidal insect antifeedants from Virola calophylla]] | ||
|Howard Miles, Ana Maria Ly, Shirley A. Randle, Paul A. Hedin, Marcus L. Burks Warb Journal of agricultural and food chemistry September 1987 Volume 35, Issue 5 D pp 794–797 | |||
|0px | |||
}} | |||
{{FileReference | |||
|[[Image:Page_white_acrobat.png]] | |||
|[[Media:bufo alvarius - a potent hallucinogen.pdf|Bufo alvarius - a potent hallucinogen]] | |||
| | | | ||
|0px | |0px | ||
| Line 281: | Line 275: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:entheogens and education potential.pdf|Entheogens and education potential]] | ||
| | | | ||
|0px | |0px | ||
| Line 287: | Line 281: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:hallucinogens and redemption.pdf|Hallucinogens and redemption]] | ||
| | | | ||
|0px | |0px | ||
| Line 293: | Line 287: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:HPPD - flashbacks.pdf|HPPD - flashbacks]] | ||
| | | | ||
|0px | |0px | ||
| Line 299: | Line 293: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:JPharmBioAn-41-3-872.pdf|JPharmBioAn-41-3-872]] | ||
| | | | ||
|0px | |0px | ||
| Line 305: | Line 299: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:Mining_Recepterome_Review_JBC.pdf|Mining_Recepterome_Review_JBC]] | ||
| | | | ||
|0px | |0px | ||
}} | }} | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:natural hallucinogens growing in USA.pdf|Natural hallucinogens growing in USA]] | ||
| | | | ||
|0px | |0px | ||
| Line 325: | Line 311: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:Nichols - Hallucinogens.pdf|Nichols - Hallucinogens]] | ||
| | | | ||
|0px | |0px | ||
| Line 331: | Line 317: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:pharmañopo - Yopo pharmacology.pdf|Pharmañopo - Yopo pharmacology]] | ||
| | | | ||
|0px | |0px | ||
| Line 337: | Line 323: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:pharmepena - epena pharmacology.pdf|Pharmepena - epena pharmacology]] | ||
| | | | ||
|0px | |0px | ||
| Line 343: | Line 329: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:Proposed Mechanism for Dreams and Sleep.pdf|Proposed Mechanism for Dreams and Sleep]] | ||
| | | | ||
|0px | |0px | ||
| Line 349: | Line 335: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:psychedelic adverse effects.pdf|Psychedelic adverse effects]] | ||
| | | | ||
|0px | |0px | ||
}} | }} | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:Psychointegrators multidisciplinary approach.pdf|Psychointegrators multidisciplinary approach]] | ||
| | | | ||
|0px | |0px | ||
| Line 371: | Line 347: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:Psychopharmacology of hallucinogens.pdf|Psychopharmacology of hallucinogens]] | ||
| | | | ||
|0px | |0px | ||
| Line 377: | Line 353: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:psychosis and hallucinogens consciousness model.pdf|Psychosis and hallucinogens consciousness model]] | ||
| | | | ||
|0px | |0px | ||
| Line 383: | Line 359: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:reducing drug problems with set and setting.pdf|Reducing drug problems with set and setting]] | ||
| | | | ||
|0px | |0px | ||
| Line 389: | Line 365: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:serotonin and hallucinogens.pdf|Serotonin and hallucinogens]] | ||
| | | | ||
|0px | |0px | ||
| Line 395: | Line 371: | ||
{{FileReference | {{FileReference | ||
|[[Image:Page_white_acrobat.png]] | |[[Image:Page_white_acrobat.png]] | ||
|[[Media: | |[[Media:study of Values of psychedelic users.pdf|Study of Values of psychedelic users]] | ||
| | | | ||
}} | }} | ||
[[Category:Supplementary Reference]] | [[Category:Supplementary Reference]] | ||
Latest revision as of 10:43, 24 October 2011
 |
Note: | This page is a work in progress -- its content throughout is not yet complete. |
Ayahuasca
|
Ayahuasca and SSRI Interactions | Callaway, J.T., C.S. Grob. (October-December 1998). Journal of Psychoactive Drugs. pp. 367-369. |
|
|
Ayahuasca Adolescents ritual use | Doering-Silveira et al. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2). pp. 141-144. |
|
|
ayahuasca first time psychological after effects | Hoffman et al. (Spring 2001). Multidisciplinary Association for Psychedelic Studies. pp. 25-30. |
|
|
Ayahuasca and human destiny | McKenna, Dennis J. (June 2005). Journal of Psychoactive Drugs. Vol. 37 (2) pp. 231-234. |
|
|
Another Ayahuasca EEG study | Riba et al. (2002). British Journal of Clinical Pharmacology. Vol. 53. Blackwell Science Ltd. pp. 617-628. |
|
|
Ayahuasca in adolescence psychiatric evaluation |
|
|
ayahuasca in cross cultural perspective |
|
|
Ayahuasca neuroimaging |
|
|
Bringing Ayahuasca to clinical laboratory |
|
|
Effects of ayahuasca on panic and anxiety.pdf |
|
|
Globalization of ayahuasca |
|
|
Human pharmacology of ayahuasca |
|
|
Pharmacokinetics of hoasca in healthy humans |
|
|
Risk assessment of ritual ayahuasca use |
|
|
Thesis - Ayahuascapharmacology part1 |
|
|
Thesis - ayahuascapharmacology part2 |
|
|
Various alkaloid profiles in aya decoction |
DMT
|
|
DMT and BCarbolines in human plasma after dose |
|
|
DMT endogenous anxiolytic role |
|
|
DMT in psychiatric patients |
|
|
DMT psychopharmacology |
Ibogaine
|
|
Fatalities after ibogaine use |
|
|
Ibogaine and cocaine abuse |
|
|
Ibogaine and facilitation of memory retrieval |
|
|
Ibogaine mechanisms of anti addiction |
|
|
Ibogaine safety and efficacy |
LSD
|
|
Long term effects of LSD |
|
|
Therapy with LSD |
Peyote
|
|
A Study on mescaline in human subjects |
|
|
Peyote long term psychological cognitive effects |
|
|
Prehistoric peyote use |
Psilocybin
|
|
Cluster headache lsd psilocybin |
|
|
Effects of psilocybin on humans |
|
|
Effects of psilocybin on perception of time |
|
|
Psilocybin and mystical experiences |
|
|
Psilocybin and OCD |
|
|
Psilocybin investigator brochure |
|
|
Psilocybin, attention and working memory |
|
|
Psychedelic mushrooms in buddhist tradition |
Salvia Divinorum
|
|
Salvia divinorum pattern of use |
|
|
Salv_A_PNAS |
Other
|
|
Alkaloidal insect antifeedants from Virola calophylla | Howard Miles, Ana Maria Ly, Shirley A. Randle, Paul A. Hedin, Marcus L. Burks Warb Journal of agricultural and food chemistry September 1987 Volume 35, Issue 5 D pp 794–797 |
|
|
Bufo alvarius - a potent hallucinogen |
|
|
Entheogens and education potential |
|
|
Hallucinogens and redemption |
|
|
HPPD - flashbacks |
|
|
JPharmBioAn-41-3-872 |
|
|
Mining_Recepterome_Review_JBC |
|
|
Natural hallucinogens growing in USA |
|
|
Nichols - Hallucinogens |
|
|
Pharmañopo - Yopo pharmacology |
|
|
Pharmepena - epena pharmacology |
|
|
Proposed Mechanism for Dreams and Sleep |
|
|
Psychedelic adverse effects |
|
|
Psychointegrators multidisciplinary approach |
|
|
Psychopharmacology of hallucinogens |
|
|
Psychosis and hallucinogens consciousness model |
|
|
Reducing drug problems with set and setting |
|
|
Serotonin and hallucinogens |
|
|
Study of Values of psychedelic users |
